2024 Program with Abstracts

Continuing Education Session: Patient Specific QA - Lombardy/Umbria

le 6 juin 2024 from 16h00 CDT to 17h00 CDT

Patient Specific QA


Kyle Malkoske, Royal Victoria Regional Health Centre, Barrie, Ontario

Jan Seuntjens, Princess Margaret Cancer Centre, Toronto, Ontario



PSQA: Setting the Stage - Andrea McNiven, Tom Baker Cancer Centre, Calgary, Alberta

Measurement-based PSQA - Eric Reynard, PEI Cancer Treatment Centre, Charlottetown, PEI

Calculation-based PSQA, Transit Dosimetry, and Log Files - Tony Popescu, BCCA Vancouver, BC

Landscape of PSQA Practice in Canada: Results of a 2024 Survey - Gordon Chan, Juravinski Cancer Centre, Hamilton, Ontario



Patient Specific Quality Assurance (PSQA) programs are essential for validating the dosimetric accuracy of intensity modulated radiation treatment plans (IMRT, VMAT, etc). Numerous publications from COMP and AAPM highlight the significance of PSQA and offer guidance on establishing comprehensive PSQA programs. Traditionally, PSQA has been primarily measurement-based, involving the comparison of measurements to treatment plans recalculated in a phantom geometry and/or array detector. However, this method has several limitations and strains institutional resources, especially with the increased use of IMRT/VMAT over the past decade. New PSQA approaches have been developed to enhance the effectiveness of PSQA while reducing the resource burden. This continuing education session aims to review the current PSQA practices in Canada, evaluating the benefits and drawbacks of different methods, with a focus on ensuring